Nomura Holdings Inc. Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

Nomura Holdings Inc. purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 22,539 shares of the company's stock, valued at approximately $523,000.

A number of other large investors have also recently bought and sold shares of the stock. JPMorgan Chase & Co. grew its holdings in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after purchasing an additional 344,875 shares during the last quarter. MetLife Investment Management LLC lifted its holdings in Option Care Health by 7.8% during the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after purchasing an additional 14,311 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. grew its stake in Option Care Health by 38.1% during the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after buying an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Option Care Health during the fourth quarter worth about $327,000. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on OPCH shares. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. JMP Securities restated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Trading Up 2.1%

OPCH traded up $0.65 during mid-day trading on Tuesday, reaching $32.06. The stock had a trading volume of 98,096 shares, compared to its average volume of 1,855,957. The firm's fifty day simple moving average is $32.93 and its two-hundred day simple moving average is $29.45. The stock has a market capitalization of $5.25 billion, a P/E ratio of 26.88, a P/E/G ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.26 earnings per share. On average, equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.